SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001104659-20-023924
Filing Date
2020-02-21
Accepted
2020-02-21 16:42:14
Documents
17
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A inva-20191231x10ka16146.htm   iXBRL 10-K/A 1174809
2 EX-23.1 ex-23d1.htm EX-23.1 3529
3 EX-23.2 ex-23d2.htm EX-23.2 6728
4 EX-31.1 ex-31d1.htm EX-31.1 11447
5 EX-31.2 ex-31d2.htm EX-31.2 10653
6 EX-32 ex-32.htm EX-32 13307
  Complete submission text file 0001104659-20-023924.txt   1476435

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA inva-20191231.xsd EX-101.SCH 2520
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE inva-20191231_lab.xml EX-101.LAB 23911
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inva-20191231_pre.xml EX-101.PRE 14309
19 EXTRACTED XBRL INSTANCE DOCUMENT inva-20191231x10ka16146_htm.xml XML 9097
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-30319 | Film No.: 20640680
SIC: 2834 Pharmaceutical Preparations